Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/2836
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Toohey, T. | en_US |
dc.contributor | Wallace, Sharon | en_US |
dc.contributor | Toohey, Michael | en_US |
dc.contributor | Francis, I. | en_US |
dc.date.accessioned | 2024-11-29T04:18:10Z | - |
dc.date.available | 2024-11-29T04:18:10Z | - |
dc.date.issued | 2024 | - |
dc.identifier.govdoc | 02779 | en_US |
dc.identifier.uri | http://hdl.handle.net/11054/2836 | - |
dc.description.abstract | Intravesical Bacillus Calmette-Guérin (BCG) administration was used to treat bladder carcinoma in a woman in her 60s. Severe bilateral non-granulomatous anterior uveitis and gross papillitis developed subsequently. The severe BCG-induced bilateral uveitis and papillitis were treated with high dose oral corticosteroids, with topical steroids and cycloplegics. Resolution of her ocular symptoms and signs eventuated. On lumbar puncture, no evidence of systemic spread of the BCG was found. Visual acuity returned to 6/9 in each eye with subsequent resolution of papillitis. Repeat cystoscopy demonstrated no evidence of recurrent bladder tumour. Hypersensitivity reactions are well recognised with Tubercle bacilli. While both hypersensitivity reactions and dissemination of BCG throughout the body have been previously documented, the literature demonstrates that this case is the first example in which papillitis and bilateral uveitis were the prominent ophthalmological features. | en_US |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2024-10-29T02:12:01Z No. of bitstreams: 0 | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2024-11-29T04:18:10Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2024-11-29T04:18:10Z (GMT). No. of bitstreams: 0 Previous issue date: 2024 | en |
dc.title | Papillitis and uveitis complicating Bacillus Calmette-Guérin immunotherapy. | en_US |
dc.type | Journal Article | en_US |
dc.type.specified | Article | en_US |
dc.bibliographicCitation.title | BMJ Case Report | en_US |
dc.bibliographicCitation.volume | 15 | en_US |
dc.bibliographicCitation.issue | 5 | en_US |
dc.bibliographicCitation.stpage | e247578 | en_US |
dc.subject.healththesaurus | IRIS | en_US |
dc.subject.healththesaurus | URINARY AND GENITAL TRACT DISORDERS | en_US |
dc.subject.healththesaurus | VISUAL PATHWAY | en_US |
dc.identifier.doi | https://doi.org/10.1136/bcr-2021-247578 | en_US |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.